Last reviewed · How we verify
NCT03274726: NHANES
Iron Status of Women and Young Children in the United States
trial in Iron-deficiency in 5,000 participants. Completed in 1 December 2010.
1 December 2010
Quick facts
| Lead sponsor | Centers for Disease Control and Prevention |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 January 1999 |
| Primary completion | 1 December 2010 |
| Estimated completion | 1 December 2010 |
Conditions studied
- Iron-deficiency — all drugs for Iron-deficiency →
- Nutritional Deficiency — all drugs for Nutritional Deficiency →
Sponsor
Centers for Disease Control and Prevention — full company profile →
Who can join
Adults 12 Months to 49, any sex, with Iron-deficiency or Nutritional Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This analysis describes the distribution of TBI and the prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) among toddlers, non-pregnant women, and pregnant women.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Iron status of toddlers, nonpregnant females, and pregnant females in the United States.
Gupta PM, Hamner HC, Suchdev PS, Flores-Ayala R, et al · · 2017 · cited 81× · PMID 29070559 · DOI 10.3945/ajcn.117.155978
Verify or expand the search:
- PubMed search for NCT03274726
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Iron-deficiency
Currently open trials in the same condition.
- NCT05407987 — Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) · Phase 3 · recruiting
- NCT06270498 — Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure · Phase 4 · recruiting
- NCT05913414 — Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT05340465 — Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants · Phase 2 · recruiting
- NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting
Other Centers for Disease Control and Prevention trials
Trials by the same sponsor.
- NCT06962904 — CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults · Phase 1 · active not recruiting
- NCT06485258 — CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults · Phase 1 · completed
- NCT05766267 — Short-course Regimens for the Treatment of Pulmonary Tuberculosis · Phase 2, PHASE3 · active not recruiting
- NCT06045923 — Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV · recruiting
- NCT06054269 — Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03274726 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centers for Disease Control and Prevention
- Last refreshed: 23 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03274726.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing